Monash Health’s specialist Cancer Centre in Moorabbin is the first Australian site to participate in an international clinical trial offering eligible patients with early stage and low risk breast cancer intraoperative radiotherapy.
The study will be assessing the feasibility, efficacy and safety of delivering a single dose of radiotherapy during an operation using a newly acquired device – (The Xoft® Axxent® Electronic Brachytherapy (eBx®) System®).
This new trial treatment will, in many patients, avoid the need for 3-6 weeks of daily radiotherapy treatment.
The Intraoperative Radiotherapy trial is open and actively recruiting. For further details contact the clinical trials co-ordinator, Ashika Singh (Ashika.Singh@monashhealth.org)